Adds Monday News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(Bloomberg) -- Australia’s central bank is set to resume a pause in interest-rate increases as latest data pointing to slower home-price growth and inflation suggest previous tightening is gaining traction.Most Read from BloombergAlaska Air Agrees to Buy Hawaiian in $1.9 Billion DealBitcoin Hits $40,000 Level for the First Time Since May 2022KISS Avatars Go On Tour After Paul Stanley, Gene Simmons RetireUS Warns Iran-Backed Houthis After Attacks on Red Sea ShippingEerie Calm in S&P 500 Signals H

JPMorgan, BofA See Scope for Longer S. Africa Stock Rally Bloomberg 2/1/2021 Adelaide Changole (Bloomberg) -- South African stocks have made their best start to the year since 2012, even after last-week’s pullback, and JPMorgan Chase & Co. and Bank of America are among those predicting further gains. A global appetite for riskier assets has propelled emerging market inflows and the Johannesburg exchange is set to benefit from its heavy weighting in mining stocks as China’s economy emerges from the pandemic. Add to this a global tech rally driving gains in index giant Nas...

Agios to Sell Cancer Portfolio to Servier for $1.8 Billion Bloomberg 12/21/2020 Emma Court (Bloomberg) -- Agios Pharmaceuticals Inc. said it agreed to sell its portfolio of oncology drugs to Servier Pharmaceuticals LLC for $1.8 billion in a move that will increase the biotechnology company’s focus on treatments for genetic diseases. Included in the pact announced Monday with closely held Servier are two drugs for acute myeloid leukemia, Tibsovo, and Idhifa, which Agios co-commercializes with Bristol-Myers Squibb Co. The drugs are expected to bring Agios sales this year of ...